Designing The Future Of Dermatology And Venereology

October 2022 in “ European medical journal ”

Aslı Bilgiç Temel, Dédée F. Murrell

frontal fibrosing alopecia androgenetic alopecia systemic therapies biologics hair loss hair thinning

TLDR The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

The 31st Congress of the European Academy of Dermatology and Venereology (EADV) in September 2022 focused on nail and hair disorders, and treatment safety amid COVID-19. Over 600 speakers presented 170 sessions, with a significant focus on nail diseases. Michela Starace highlighted the limited safety and efficacy data for over-the-counter supplements used for nail disorders. The congress also discussed the increasing prevalence of frontal fibrosing alopecia, a hair disorder causing irreversible hair loss, and its potential association with daily care products. Androgenetic alopecia, the most common hair loss type, was another key topic, with emerging therapies being discussed. Luís Puig emphasized the higher risk of severe COVID-19 in unvaccinated, immunosuppressed patients, but noted that systemic therapies and biologics do not increase this risk. He suggested choosing therapies with longer half-lives to avoid sudden relapses if treatment schedules are disrupted.

View this study on emjreviews.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 355 results

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 1 month ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Testosterone and hair loss seeming irrelevance

in Research/Science 82 upvotes 1 year ago

The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

community Fibrosing alopecia in a pattern distribution

in Research/Science 14 upvotes 6 months ago

A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

community 1 and a half years on fin - hair is way worse.

in Finasteride/Dutasteride 9 upvotes 1 year ago

The user reported worsening hair loss after 1.5 years on finasteride, questioning if chronic iron deficiency could be a cause. They noted no side effects from finasteride.

community Actor Jacob Batalon, 26, has a receding hairline. I thought it was pretty cool to see a younger actor being successful, despite dealing with hair loss. His most well known role is Ned Leeds in the Marvel Cinematic Universe, and he is currently the CEO of Sex.

in Satire 498 upvotes 1 year ago

Actor Jacob Batalon's receding hairline and how it is a sign of his success despite dealing with hair loss, with some people suggesting he may be using treatments such as Minoxidil or Finasteride to manage it.

community scarring alopecia awareness in this community

in Chat 33 upvotes 1 year ago

Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

Related Research

2 / 2 results

research Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar

1 citations, July 2021 in “Acta dermatovenerologica Croatica”

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

research Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar

July 2021 in “PubMed”

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.